{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T22:31:28Z","timestamp":1788820288828,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,10,8]],"date-time":"2023-10-08T00:00:00Z","timestamp":1696723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,8]],"date-time":"2023-10-08T00:00:00Z","timestamp":1696723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"RheumaDatenRhePort GbR"},{"DOI":"10.13039\/100008792","name":"Novartis Pharma GmbH","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-023-05463-7","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T07:22:16Z","timestamp":1696836136000},"page":"653-661","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Radiographic and non-radiographic axial spondyloarthritis are not routinely distinguished in everyday clinical care: an analysis of real-world data from rheumatology practices"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2588-7547","authenticated-orcid":false,"given":"Stefan","family":"Kleinert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2543-0491","authenticated-orcid":false,"given":"Florian","family":"Schuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9257-1707","authenticated-orcid":false,"given":"Praxedis","family":"Rapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1929-8977","authenticated-orcid":false,"given":"Monika","family":"Ronneberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4167-8989","authenticated-orcid":false,"given":"Joerg","family":"Wendler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9331-7168","authenticated-orcid":false,"given":"Patrizia","family":"Sternad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8012-1468","authenticated-orcid":false,"given":"Florian","family":"Popp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8084-4497","authenticated-orcid":false,"given":"Peter","family":"Bartz-Bazzanella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9780-7174","authenticated-orcid":false,"given":"Cay","family":"von der Decken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1362-7326","authenticated-orcid":false,"given":"Kirsten","family":"Karberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2132-8369","authenticated-orcid":false,"given":"Georg","family":"Gauler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2471-1411","authenticated-orcid":false,"given":"Patrick","family":"Wurth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8124-2111","authenticated-orcid":false,"given":"Susanna","family":"Sp\u00e4thling-Mestekemper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0538-1717","authenticated-orcid":false,"given":"Christoph","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1076-5560","authenticated-orcid":false,"given":"Wolfgang","family":"Vorbr\u00fcggen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1856-3085","authenticated-orcid":false,"given":"Martin","family":"Welcker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,8]]},"reference":[{"key":"5463_CR1","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s40744-019-00172-9","volume":"6","author":"PJ Mease","year":"2019","unstructured":"Mease PJ, Liu M, Rebello S et al (2019) Comparative disease burden in patients with rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis: data from two Corrona registries. Rheumatol Ther 6:529\u2013542. https:\/\/doi.org\/10.1007\/s40744-019-00172-9","journal-title":"Rheumatol Ther"},{"key":"5463_CR2","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1007\/s00296-018-4124-z","volume":"38","author":"K Kr\u00fcger","year":"2018","unstructured":"Kr\u00fcger K, von Hin\u00fcber U, Meier F et al (2018) Ankylosing spondylitis causes high burden to patients and the healthcare system: results from a German claims database analysis. Rheumatol Int 38:2121\u20132131. https:\/\/doi.org\/10.1007\/s00296-018-4124-z","journal-title":"Rheumatol Int"},{"key":"5463_CR3","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","volume":"76","author":"D van der Heijde","year":"2017","unstructured":"van der Heijde D, Ramiro S, Landew\u00e9 R et al (2017) 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis 76:978\u2013991. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210770","journal-title":"Ann Rheum Dis"},{"key":"5463_CR4","doi-asserted-by":"publisher","first-page":"iv18","DOI":"10.1093\/rheumatology\/keaa422","volume":"59","author":"X Michelena","year":"2020","unstructured":"Michelena X, L\u00f3pez-Medina C, Marzo-Ortega H (2020) Non-radiographic versus radiographic axSpA: what\u2019s in a name? Rheumatology (Oxford) 59:iv18\u2013iv24. https:\/\/doi.org\/10.1093\/rheumatology\/keaa422","journal-title":"Rheumatology (Oxford)"},{"key":"5463_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/ard-2022-223296","volume":"82","author":"S Ramiro","year":"2023","unstructured":"Ramiro S, Nikiphorou E, Sepriano A et al (2023) ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis 82:19\u201334. https:\/\/doi.org\/10.1136\/ard-2022-223296","journal-title":"Ann Rheum Dis"},{"key":"5463_CR6","doi-asserted-by":"publisher","first-page":"e001108","DOI":"10.1136\/rmdopen-2019-001108","volume":"5","author":"C L\u00f3pez-Medina","year":"2019","unstructured":"L\u00f3pez-Medina C, Ramiro S, van der Heijde D et al (2019) Characteristics and burden of disease in patients with radiographic and non-radiographic axial spondyloarthritis: a comparison by systematic literature review and meta-analysis. RMD Open 5:e001108. https:\/\/doi.org\/10.1136\/rmdopen-2019-001108","journal-title":"RMD Open"},{"key":"5463_CR7","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1080\/1744666x.2018.1477591","volume":"14","author":"M Protopopov","year":"2018","unstructured":"Protopopov M, Poddubnyy D (2018) Radiographic progression in non-radiographic axial spondyloarthritis. Expert Rev Clin Immunol 14:525\u2013533. https:\/\/doi.org\/10.1080\/1744666x.2018.1477591","journal-title":"Expert Rev Clin Immunol"},{"issue":"suppl 1","key":"5463_CR8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1136\/annrheumdis-2022-eular.2946","volume":"81","author":"D Poddubnyy","year":"2022","unstructured":"Poddubnyy D, Sieper J, Akar S et al (2022) Radiographic progression from non-radiographic to radiographic axial spondyloarthritis; results from a 5-year multicountry prospective observational study (abstract OP0149). Ann Rheum Dis 81(suppl 1):96. https:\/\/doi.org\/10.1136\/annrheumdis-2022-eular.2946","journal-title":"Ann Rheum Dis"},{"key":"5463_CR9","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1136\/annrheumdis-2014-206971","volume":"74","author":"P Mandl","year":"2015","unstructured":"Mandl P, Navarro-Comp\u00e1n V, Terslev L et al (2015) EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice. Ann Rheum Dis 74:1327\u20131339. https:\/\/doi.org\/10.1136\/annrheumdis-2014-206971","journal-title":"Ann Rheum Dis"},{"key":"5463_CR10","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/ard.2009.108233","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, van der Heijde D, Landew\u00e9 R et al (2009) The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68:777\u2013783. https:\/\/doi.org\/10.1136\/ard.2009.108233","journal-title":"Ann Rheum Dis"},{"key":"5463_CR11","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1136\/annrheumdis-2015-208642","volume":"75","author":"RGW Lambert","year":"2016","unstructured":"Lambert RGW, Bakker PAC, van der Heijde D et al (2016) Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group. Ann Rheum Dis 75:1958\u20131963. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208642","journal-title":"Ann Rheum Dis"},{"key":"5463_CR12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S van der Linden","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361\u2013368. https:\/\/doi.org\/10.1002\/art.1780270401","journal-title":"Arthritis Rheum"},{"key":"5463_CR13","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1136\/ard-2022-222986","volume":"81","author":"D Poddubnyy","year":"2022","unstructured":"Poddubnyy D, Diekhoff T, Baraliakos X et al (2022) Diagnostic evaluation of the sacroiliac joints for axial spondyloarthritis: should MRI replace radiography? Ann Rheum Dis 81:1486\u20131490. https:\/\/doi.org\/10.1136\/ard-2022-222986","journal-title":"Ann Rheum Dis"},{"key":"5463_CR14","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/art.38776","volume":"66","author":"A Deodhar","year":"2014","unstructured":"Deodhar A, Reveille JD, van den Bosch F et al (2014) The concept of axial spondyloarthritis: joint statement of the Spondyloarthritis Research and Treatment Network and the Assessment of SpondyloArthritis international Society in response to the US Food and Drug Administration\u2019s comments and concerns. Arthritis Rheumatol 66:2649\u20132656. https:\/\/doi.org\/10.1002\/art.38776","journal-title":"Arthritis Rheumatol"},{"key":"5463_CR15","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s12891-018-2211-7","volume":"19","author":"JA Walsh","year":"2018","unstructured":"Walsh JA, Pei S, Penmetsa GK et al (2018) Cohort identification of axial spondyloarthritis in a large healthcare dataset: current and future methods. BMC Muculoskelet Disord 19:317. https:\/\/doi.org\/10.1186\/s12891-018-2211-7","journal-title":"BMC Muculoskelet Disord"},{"key":"5463_CR16","unstructured":"Neurology and pain management coding alert: get a grip on new spondyloarthritis code set for 2022 (2021) https:\/\/www.aapc.com\/codes\/coding-newsletters\/my-neurology-coding-alert\/icd-10-2022-get-a-grip-on-new-spondyloarthritis-code-set-for-2022-170532-article. Accessed 7 Aug 2023"},{"key":"5463_CR17","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1093\/rheumatology\/kez171","volume":"58","author":"SS Zhao","year":"2019","unstructured":"Zhao SS, Ermann J, Xu C et al (2019) Comparison of comorbidities and treatment between ankylosing spondylitis and non-radiographic axial spondyloarthritis in the United States. Rheumatology (Oxford) 58:2025\u20132030. https:\/\/doi.org\/10.1093\/rheumatology\/kez171","journal-title":"Rheumatology (Oxford)"},{"key":"5463_CR18","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1093\/rheumatology\/kez375","volume":"59","author":"SS Zhao","year":"2020","unstructured":"Zhao SS, Hong C, Cai T et al (2020) Incorporating natural language processing to improve classification of axial spondyloarthritis using electronic health records. Rheumatology (Oxford) 59:1059\u20131065. https:\/\/doi.org\/10.1093\/rheumatology\/kez375","journal-title":"Rheumatology (Oxford)"},{"issue":"suppl 1","key":"5463_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00393-019-0670-3","volume":"78","author":"U Kiltz","year":"2019","unstructured":"Kiltz U, Braun J, Becker A et al (2019) Long version on the S3 guidelines for axial spondyloarthritis including Bechterew\u2019s disease and early forms, update 2019: evidence-based guidelines of the German Society for Rheumatology (DGRh) and participating medical scientific specialist societies and other organizations. Z Rheumatol 78(suppl 1):3\u201364. https:\/\/doi.org\/10.1007\/s00393-019-0670-3","journal-title":"Z Rheumatol"},{"key":"5463_CR20","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1002\/art.41042","volume":"71","author":"MM Ward","year":"2019","unstructured":"Ward MM, Deodhar A, Gensler LS et al (2019) 2019 update of the American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheumatol 71:1599\u20131613. https:\/\/doi.org\/10.1002\/art.41042","journal-title":"Arthritis Rheumatol"},{"key":"5463_CR21","doi-asserted-by":"publisher","first-page":"e28164","DOI":"10.2196\/28164","volume":"23","author":"S Kleinert","year":"2021","unstructured":"Kleinert S, Bartz-Bazzanella P, von der Decken C, RHADAR Group (2021) A real-world rheumatology registry and research consortium: the German RheumaDatenRhePort (RHADAR) Registry. J Med Internet Res 23:e28164. https:\/\/doi.org\/10.2196\/28164","journal-title":"J Med Internet Res"},{"key":"5463_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00296-022-05248-4","volume":"43","author":"S Kleinert","year":"2023","unstructured":"Kleinert S, Schuch F, Rapp P et al (2023) Impairment in cognitive function in patients with axial spondyloarthritis and psoriatic arthritis. Rheumatol Int 43:89\u201397. https:\/\/doi.org\/10.1007\/s00296-022-05248-4","journal-title":"Rheumatol Int"},{"key":"5463_CR23","unstructured":"Ethik-Kommission der Bayerischen Landes\u00e4rztekammer. Application documents if the EK-BL\u00c4K is a primary advisor according to \u00a715 BO. https:\/\/ethikkommission.blaek.de\/studien\/sonstige-studien\/antragsunterlagen-ek-primarberatend-15-bo. Accessed 14 Aug 2023."},{"key":"5463_CR24","unstructured":"National Ankylosing Spondylitis Society (2016) The Bath indices. https:\/\/nass.co.uk\/wp-content\/uploads\/2018\/09\/Bath-Indices.pdf. Accessed 09 Aug 2023."},{"key":"5463_CR25","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1002\/acr.20575","volume":"63","author":"J Zochling","year":"2011","unstructured":"Zochling J (2011) Measures of symptoms and disease status in ankylosing spondylitis. Arthritis Care Res 63:S47-58. https:\/\/doi.org\/10.1002\/acr.20575","journal-title":"Arthritis Care Res"},{"key":"5463_CR26","doi-asserted-by":"publisher","first-page":"e002067","DOI":"10.1136\/rmdopen-2021-002067","volume":"8","author":"A Ciurea","year":"2022","unstructured":"Ciurea A, Kissling S, B\u00fcrki K et al (2022) Current differentiation between radiographic and non-radiographic axial spondyloarthritis is of limited benefit for prediction of important clinical outcomes: data from a large, prospective, observational cohort. RMD Open 8:e002067. https:\/\/doi.org\/10.1136\/rmdopen-2021-002067","journal-title":"RMD Open"},{"key":"5463_CR27","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1093\/rheumatology\/keab901","volume":"61","author":"D Poddubnyy","year":"2022","unstructured":"Poddubnyy D, Sieper J, Akar S et al (2022) Characteristics of patients with axial spondyloarthritis by geographic regions: PROOF multicountry observational study baseline results. Rheumatology (Oxford) 61:3299\u20133308. https:\/\/doi.org\/10.1093\/rheumatology\/keab901","journal-title":"Rheumatology (Oxford)"},{"key":"5463_CR28","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1007\/s10067-021-05642-6","volume":"40","author":"T Hunter","year":"2021","unstructured":"Hunter T, Sandoval D, Booth N, Holdsworth E, Deodhar A (2021) Comparing symptoms, treatment patterns, and quality of life of ankylosing spondylitis and non-radiographic axial spondyloarthritis patients in the USA: findings from a patient and rheumatologist survey. Clin Rheumatol 40:3161\u20133167. https:\/\/doi.org\/10.1007\/s10067-021-05642-6","journal-title":"Clin Rheumatol"},{"issue":"suppl 1","key":"5463_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2023-eular.2967","volume":"82","author":"ML Marques","year":"2023","unstructured":"Marques ML, Ramiro S, Van Lunteren M et al (2023) Can axial spondyloarthritis unequivocally be diagnosed by rheumatologists in patients with chronic back pain of less than two years duration? Main results of the SPondyloarthritis Caught Early (SPACE) cohort (abstract OP0005). Ann Rheum Dis 82(suppl 1):3\u20134. https:\/\/doi.org\/10.1136\/annrheumdis-2023-eular.2967","journal-title":"Ann Rheum Dis"},{"key":"5463_CR30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1136\/annrheumdis-2021-220136","volume":"81","author":"T Diekhoff","year":"2022","unstructured":"Diekhoff T, Eshed I, Radny F et al (2022) Choose wisely: imaging for the diagnosis of axial spondyloarthritis. Ann Rheum Dis 81:237\u2013242. https:\/\/doi.org\/10.1136\/annrheumdis-2021-220136","journal-title":"Ann Rheum Dis"},{"key":"5463_CR31","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1093\/rheumatology\/keac432","volume":"62","author":"M Protopopov","year":"2023","unstructured":"Protopopov M, Proft F, Wichuk S et al (2023) Comparing MRI and conventional radiography for the detection of structural changes indicative of axial sponydloarthritis in the ASAS cohort. Rheumatology (Oxford) 62:1631\u20131635. https:\/\/doi.org\/10.1093\/rheumatology\/keac432","journal-title":"Rheumatology (Oxford)"},{"key":"5463_CR32","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/acr.24459","volume":"72","author":"A Sepriano","year":"2022","unstructured":"Sepriano A, Ramiro S, van der Heijde D et al (2022) Imaging outcomes for axial spondyloarthritis and sensitivity to change: a five-year analysis of the DESIR cohort. Arthritis Care Res (Hoboken) 72:251\u2013258. https:\/\/doi.org\/10.1002\/acr.24459","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"5463_CR33","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1007\/s00296-018-4130-1","volume":"38","author":"I Kucybala","year":"2018","unstructured":"Kucybala I, Urbanik A, Wojciechowski W (2018) Radiologic approach to axial spondyloarthritis: where are we now and where are we heading? Rheumatol Int 38:1753\u20131762. https:\/\/doi.org\/10.1007\/s00296-018-4130-1","journal-title":"Rheumatol Int"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-023-05463-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-023-05463-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-023-05463-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T21:36:03Z","timestamp":1709933763000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-023-05463-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,8]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["5463"],"URL":"https:\/\/doi.org\/10.1007\/s00296-023-05463-7","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,8]]},"assertion":[{"value":"7 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SK, PB-B, CVdD, KK, GG, SS-M, CK, WV, and MW are members of RheumaDatenRhePort. SK received grants or contracts from Abbvie, Novartis, and Sparrow for phase 2\/3 clinical trials, received consulting fees or honoraria from Abbvie, Celgene, Galapagos, Novartis, and Siemens Healthineers, and participated on a data safety monitoring or advisory board for Abbvie. FS received consulting or speaker\u2019s fees from Abbvie, Galapagos, Lilly, Novartis, and Rheumaakademie and travel or meeting support from Abbvie. MR received consulting or speaking fees from Abbvie, BMS, Galapagos, Janssen, Novartis, and UCB, travel or meeting support from Pfizer, and participated on data safety monitoring or advisory boards for Abbvie, Galapagos, Novartis, and UCB. JW received consulting fees from Abbvie. FP received consulting fees from Abbvie, Boehringer, Galapagos, Medac, and Viatris. PBB received speaking fees from AbbVie, Boehringer Ingelheim, Chugai\/Roche, Janssen-Cilag, Novartis, Pfizer, and UCB, travel or meeting support from Abbvie, and participated on a data safety monitoring or advisory board for RHADAR GbR. KK received speaking fees from Abbvie, Galapagos, Novartis, Rheumakademie, and UCB, travel or meeting support from UCB, and participated on a data safety monitoring or advisory board for RHADAR GbR. GG received speaking fees from Abbvie, Galapagos, and Novartis and travel or meeting support from Abbvie and Novartis. PW received consulting or speaking fees from Abbvie, Galapagos, Jannsen, and Medac. SSM received speaking fees from AbbVie, Boehringer Ingelheim, GSK, Janssen-Cilag, Lilly, Novartis, and UCB and participated on a data safety monitoring or advisory board for RHADAR GbR. MW received grants or contracts from AbbVie, BMS, Boehringer, Galapagos, Gilead, GSK, Hexal, Janssen, Novartis, Pfizer, and UCB, consulting or speaking fees from Abbvie, Aescu, Alexion, Amgen, Biogen, BDI, BDRH, BMS, Boehringer, Celltrion, DGRH, Fresenius, Galapagos, Gilead, GSK, Hexal, Janssen, Medac, MSD, Mundipharma, Mylan, Novartis, Pfizer, RHADAR, RheCORD, Rheumaliga, Riemser, Roche, Sanofi-Aventis, SOBI, and UCB, travel or meeting support from Abbvie, Amgen, Celltrion, Galapagos, GSK, Novartis, Pfizer, Sanofi-Aventis, and UCB, and participated on a data safety monitoring or advisory board for Abbvie, Boehringer, Fresenius, Galapagos, Gilead, GSK, Janssen, Novartis, Pfizer, Sanofi-Aventis, and UCB. PR, PS, CvdD, CK, and WV do not have any competing interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was exempted from ethical approval under German law due to the use of anonymized data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all patients prior to study start.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}